4//SEC Filing
Guerard Frederic 4
Accession 0001415889-25-018304
CIK 0001534133other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 6:25 PM ET
Size
13.1 KB
Accession
0001415889-25-018304
Insider Transaction Report
Form 4
Guerard Frederic
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-24+15,000→ 15,000 totalExercise: $1.53Exp: 2035-04-22→ Common Stock (15,000 underlying) - Award
Director Stock Option (Right to Buy)
2025-06-24+10,000→ 10,000 totalExercise: $1.53Exp: 2035-04-22→ Common Stock (10,000 underlying) - Award
Director Stock Option (Right to Buy)
2025-06-24+10,000→ 10,000 totalExercise: $1.65Exp: 2035-06-23→ Common Stock (10,000 underlying) - Award
Director Stock Option (Right to Buy)
2025-06-24+5,000→ 5,000 totalExercise: $1.53Exp: 2035-04-22→ Common Stock (5,000 underlying)
Footnotes (5)
- [F1]The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
- [F2]1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025.
- [F3]Immediately exercisable.
- [F4]1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025.
- [F5]1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders
Documents
Issuer
CalciMedica, Inc.
CIK 0001534133
Entity typeother
Related Parties
1- filerCIK 0001825009
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 6:25 PM ET
- Size
- 13.1 KB